XML 40 R26.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Quarterly Information (Unaudited) | 12 Months Ended
--- | ---
Dec. 30, 2017
Quarterly Financial Data [Abstract] |
Quarterly Information (Unaudited) | Note 18 – Quarterly Information (Unaudited) The following tables present certain quarterly financial data:
|  |  | Quarters ended
|  |  | April 1, |  | July 1, |  | September 30, |  | December 30,
|  |  | 2017 (2) |  | 2017 (2) |  | 2017 (2) |  | 2017
Net sales |  | $ | 2,922,948 |  | $ | 3,059,458 |  | $ | 3,161,083 |  | $ | 3,318,054
Gross profit |  |  | 822,920 |  |  | 839,173 |  |  | 836,054 |  |  | 900,956
Operating income |  |  | 193,968 |  |  | 210,662 |  |  | 213,548 |  |  | 241,191
Net income |  |  | 150,253 |  |  | 149,582 |  |  | 150,948 |  |  | 8,510
Amounts attributable to |  |  |  |  |  |  |  |  |  |  |  |
| Henry Schein, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  |  | 140,748 |  |  | 136,055 |  |  | 138,031 |  |  | (8,535)
Earnings (loss) per share attributable to |  |  |  |  |  |  |  |  |  |  |  |
| Henry Schein, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
| Basic |  | $ | 0.89 |  | $ | 0.86 |  | $ | 0.88 |  | $ | (0.06)
| Diluted |  |  | 0.88 |  |  | 0.86 |  |  | 0.87 |  |  | (0.06)
|  |  | Quarters ended
|  |  | March 26, |  | June 25, |  | September 24, |  | December 31,
|  |  | 2016 (1) (2) |  | 2016 (1) (2) |  | 2016 (1) (2) |  | 2016 (1) (2)
Net sales |  | $ | 2,712,956 |  | $ | 2,872,630 |  | $ | 2,865,148 |  | $ | 3,120,934
Gross profit |  |  | 777,842 |  |  | 801,469 |  |  | 787,675 |  |  | 859,487
Restructuring costs |  |  | 4,058 |  |  | 20,383 |  |  | 5,370 |  |  | 16,080
Operating income |  |  | 176,194 |  |  | 180,677 |  |  | 200,721 |  |  | 213,982
Net income |  |  | 124,533 |  |  | 133,098 |  |  | 145,291 |  |  | 153,473
Amounts attributable to |  |  |  |  |  |  |  |  |  |  |  |
| Henry Schein, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
Net income |  |  | 113,752 |  |  | 120,097 |  |  | 133,713 |  |  | 139,216
Earnings per share attributable to |  |  |  |  |  |  |  |  |  |  |  |
| Henry Schein, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
| Basic |  | $ | 0.70 |  | $ | 0.74 |  | $ | 0.83 |  | $ | 0.88
| Diluted |  |  | 0.69 |  |  | 0.73 |  |  | 0.82 |  |  | 0.86
(1) | See Note 10 - "Plans of Restructuring" for details of the restructuring costs incurred during the fiscal year of 2016.
(2) | See Item 5 - "Purchases of Equity Securities by the Issuer" for details of the 2-for-1 split of our common stock, during the third quarter of 2017.
We experience fluctuations in quarterly financial results. As a result, we may fail to meet or exceed the expectations of securities analysts and investors, which could cause our stock price to decline. Our business is subject to seasonal and other quarterly fluctuations. Revenues and profitability generally have been higher in the third and fourth quarters due to the timing of sales of seasonal products (including influenza vaccine, equipment and software products), purchasing patterns of office-based health care practitioners and year-end promotions. Revenues and profitability generally have been lower in the first quarter, primarily due to increased sales in the prior two quarters. We expect our historical seasonality of sales to continue in the foreseeable future. Quarterly results may also be materially adversely affected by a variety of other factors, including: • timing and amount of sales and marketing expenditures; • timing of pricing changes offered by our suppliers; • timing of the introduction of new products and services by our suppliers; • timing of the release of upgrades and enhancements to our technology-related products and services; • changes in or availability of supplier contracts or rebate programs; • supplier rebates based upon attaining certain growth goals; • changes in the way suppliers introduce or deliver products to market; • costs of developing new applications and services; • our ability to correctly identify customer needs and preferences and predict future needs and preferences; • uncertainties regarding potential significant breaches of data security or disruptions of our information technology systems; • unexpected regulatory actions, or government regulation generally; • exclusivity requirements with certain suppliers may prohibit us from distributing competitive products manufactured by other suppliers; • loss of sales representatives; • costs related to acquisitions and/or integrations of technologies or businesses; • costs associated with our self-insured medical and dental insurance programs; • general market and economic conditions, as well as those specific to the health care industry and related industries; • our success in establishing or maintaining business relationships; • unexpected difficulties in developing and manufacturing products; • product demand and availability or recalls by manufacturers; • exposure to product liability and other claims in the event that the use of the products we sell results in injury; • increases in shipping costs or service issues with our third-party shippers; • fluctuations in the value of foreign currencies; • restructuring costs; • the adoption or repeal of legislation; • changes in accounting principles; and • litigation or regulatory judgements, expenses or settlements Any change in one or more of these or other factors could cause our annual or quarterly financial results to fluctuate. If our financial results do not meet market expectations, our stock price may decline.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration